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Abstract
Background: Black tea is, second only to water, the most consumed beverage globally. Previously, the inhibition
of DNA methyltransferase 1 was shown by dietary polyphenols and epi-gallocatechin gallate (EGCG), the main
polyphenolic constituent of green tea, and 5-caffeoyl quinic acid, the main phenolic constituent of the green
coffee bean.
Results: We studied the inhibition of DNA methyltransferase 3a by a series of dietary polyphenols from black tea
such as theaflavins and thearubigins and chlorogenic acid derivatives from coffee. For theaflavin 3,3 digallate and
thearubigins IC50 values in the lower micro molar range were observed, which when compared to pharmacokinetic
data available, suggest an effect of physiological relevance.
Conclusions: Since Dnnmt3a has been associated with development, cancer and brain function, these data
suggest a biochemical mechanism for the beneficial health effect of black tea and coffee and a possible molecular
mechanism for the improvement of brain performance and mental health by dietary polyphenols.
Background
Black tea is, second only to water, the most consumed
beverage globally with an average per capita consump-
tion of around 550 ml per day. The annual production
of tea leaves reached a record high in 2008 with a global
harvest of 3.75. Mt [1]. Production of dried tea com-
prises 20% green, 2% oolong and the remainder black.
Following black tea, coffee is the third most consumed
beverage globally with an annual production of 9.7 Mt
and a daily consumption of around 300 ml (data from
http://www.fas.usda.gov/, obtained 1st March 2011).
Strong epidemiological evidence has repeatedly linked
the consumption both black tea [2] and coffee [3,4] to a
variety of beneficial health effects, among them is the
prevention of multifactorial diseases including cancer,
cardiovascular disease and neurological disorders as well
as a series of psychoactive responses improving
alertness, mood and general mental performance [5-8].
Recently, Unilever made an application for a health
claim, in which the black tea beverage should suppo-
sedly improve mental alertness and focus, based on stu-
dies by Nurk et al. with the activities of the two
compounds caffeine and L-theanine as the proposed
rationale [9]. While epidemiological studies link two
causally unrelated events, e. g. a beneficial health effect
with the consumption of a certain diet, with a certain
statistical probability, the molecular causes of these epi-
demiological observations are rarely known. In order to
rationalize epidemiological observations, a biological tar-
get must be identified that is mechanistically linked to
the beneficial health effect reported, as well as the speci-
fic molecules contained in the diet that interact with the
biological target in question at dietary and physiologi-
cally relevant concentrations. The search for such
matching pairs of biological targets and dietary com-
p o u n dm u s tb ec o n s i d e r e da ne x e r c i s eo ff i s h i n gi nt h e
dark, however, where enzymes known to be intimately
involved in the area in question need to be systemati-
cally screened against secondary metabolites known to
be produced by the dietary plant in question.
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have recently reported the inhibition of DNA methyl-
transferase 1 (Dnmt1) by a series of dietary polyphenols
[10] and work by Lee and co-workers on the inhibition
of the same enzyme investigating most notably epi-gal-
locatechin gallate (EGCG) [11] (the main polyphenolic
constituent of green tea) and 5-caffeoyl quinic acid [12]
(the main phenolic constituent of the green coffee
bean), and Nandakumar, showing the reduction of cellu-
lar DNA methylation after admission of (-)-epigallocate-
chin-3-gallate [13], we decided to screen the interaction
of a series of black tea and coffee polyphenols against
DNA methyltransferase 3a, another important member
of this family of enzymes.
DNA methyltransferases catalyzes methylation of
DNA at cytosine residues and play an important role in
epigenetic regulation of gene expression, X-chromosome
inactivation, genomic imprinting, and development cel-
lular aging and cell differentiation [14,15]. In mammals,
DNA methylation is catalyzed mainly by three DNA
methyltransferases [15,16]: Dnmt1, Dnmt3a, and
Dnmt3b. Dnmt1 has a high preference for hemimethy-
lated DNA and is essential for maintaining the methyla-
tion patterns during each round of DNA replication. On
the other hand, Dnmt3a and Dnmt3b modify both
unmethylated and hemimethylated DNA and are
responsible for de novo methylation during early devel-
opment. Errors in DNA methylation contribute to both
the initiation and the progression of various cancers
[17,18]. In addition, aberrant or missing DNA methyla-
tion causes many kinds of diseases which include defects
in embryonic development or brain development and
neurological defects which are also associated with
behavioral changes [19]. Hypermethylation of genes is
one of important process in cancer development, typi-
cally resulting in the repression of tumor suppressor
genes. Preventing the hypermethylation of promoter
genes by selective inhibition of methyltransferases could
pave a way for cancer treatment [20-22]. Importantly it
has been shown that upon use of methyltransferase inhi-
bitors it was possible to reactivate gene silenced by pro-
moter methylation in cancers and thus modulate gene
expression. Several efforts are directed at developing
small molecules that target DNA methyltransferases and
other elements of the machinery, as the proteins that
bind to methylated CpG; some are in clinical trials
[20-22].
Another important issue of DNA methylation is its
function in brain development. Levenson and coworkers
showed that Dnmt1 is involved in the formation of hip-
pocampus-dependent long term memory [23]. They
found that the promoters for reelin and brain-derived
neurotrophic factor (genes implicated in the induction
of synaptic plasticity in the adult hippocampus) exhibit
rapid and dramatic changes in cytosine methylation
when Dnmt1 activity was inhibited. Moreover, DNA
methyltransferase inhibitors like 5-aza-2-deoxycytidine
blocked the induction of long term potentiation at
Schaffer collateral synapses. Furthermore, Dnmt3a-
dependent DNA methylation has been reported to influ-
ence transcription of neurogenic genes [24]. Additional
studies showed that Dnmt1 and Dnmt3a regulate synap-
tic function in adult forebrain neurons [25] and Dnmt3a
affects plasticity of neurons [26].
Changes in the DNA methylation pattern of regions in
the hippocampus are associated with behavioral changes
in rat [27]. In addition, Dnmt3a has been recently
shown to affect the emotional behaviour [26]. Thus,
DNA methylation which is already known to be
involved in setting up cellular memory is also involved
in brain function. The combination of studies in cell
lines and in animal models, coupled with data obtained
from post-mortem human material provides compelling
evidence that aberrant methylation may contribute to
psychiatric diseases like schizophrenia and psychosis
[28]. Strong epidemiological evidence suggests that par-
ticularly for black tea and green tea there is an inverse
relation between intake and significant beneficial effects
on patients suffering from psychological disorders
[2,5-8]. Currently, no accepted rationale on the molecu-
lar level exists that can account for these epidemiologi-
cal findings. Dnmts are a possible biological target for
tea dietary polyphenols suggesting a molecular based
rationale for the observed biological activities.
Results
Expression and purification of Dnmt3a-C
The catalytic domain of Dnmt3a was expressed and pur-
ified following an established protocol [29,30]. The puri-
fied protein by Ni-NTA affinity chromatography was
>90% homogenous as judged from SDS-PAGE stained
with colloidal Coomassie Blue (Figure 1).
Selection and purification of black tea and coffee
polyphenols
Black tea is produced from the young green shoots of
the tea plant (Camellia sinensis), which are converted to
black tea by fermentation [31]. There are two major
processes, the ‘orthodox’ and the ‘cut-tear-curl’. In both,
the objective is to achieve efficient disruption of the cel-
lular substructure bringing phenolic compounds present
in the green tea leaf, mainly flavan-3-ols otherwise
known as catechins, into contact with polyphenol oxi-
dases and activating many other enzymes. The catechin
substrates are oxidized and extensively transformed into
novel dimeric, oligomeric and polymeric compounds.
The chemical composition of black tea brew can be
divided into (i) a series of well characterized small
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feine), carbohydrates and amino acids (including thea-
nine), and a series of glycosylated flavonoids and dimers
of catechins including most notably theaflavins together
accounting for 30-40% of the dry mass of a typical black
tea infusion, and (ii) the heterogeneous and poorly char-
acterized polyphenolic fermentation products accounting
for the remaining 60-70% [31]. This material was origin-
ally referred to as oxytheotannin and later renamed by
Roberts as thearubigins [32].
For this study, we first selected EGCG N1 and (-)-epi-
gallocatechin N4 (from green tea, also on occasions
found in black tea at low concentrations) as reference
compounds. Next we selected the four most common
theaflavin derivatives: theaflavin N2, theaflavin-3-gallate
N5, theaflavin 3’-gallate N3 and theaflavin 3, 3’-digallate
N6 (see Figure 2) [33,34]. All four compounds are
found in black tea infusions at concentrations of around
100 mM, making up 2-3% of the total content of dry
mass in typical black tea infusion. Theaflavins are struc-
turally closely related the catechins being formal dimers
of EGCG obtained through a two electron oxidation fol-
l o w e db yC - Cb o n df o r m a t i o na n dab e n z y l i ca c i dt y p e
rearrangement leading to the benztropololone core
structure. Next to theaflavins we decided to screen as
well two crude thearubigin fractions. We recently pro-
posed that thearubigins contain several thousands poly-
hydroxylated theaflavin derivatives in equilibrium with
their ortho-quinones. Theaflavins were obtained by
extraction from black tea infusion followed by purifica-
tion by preparative HPLC. The purity was assessed by
LC-tandem MS. Thearubigins were obtained from black
tea infusions using a protocol developed by Roberts [35].
For coffee polyphenols, we selected a range of natu-
rally occurring and synthetic derivatives of chlorogenic
acids. Chlorogenic acids (CGAs) are formally hydroxyl-
cinnamate esters of quinic acid with a dietary intake of
an estimated 2 g per human per day [36]. We recently
reported a total of 70 different chlorogenic acids found
in green coffee beans and selected some representative
examples containing both caffeic acid and ferulic acid
substituents [37-40]. Furthermore, we selected a range
of epimers of CGAs produced from the original second-
ary plant metabolites by roasting of the coffee beans.
Representative structures are shown in Figure 2. All
CGA derivatives were obtained through chemical synth-
esis unless stated otherwise.
Dnmt3a-C activity and inhibitors screening
The purified Dnmt3a-C was catalytically highly active
(Figure 3). For an initial screening of the twenty four
inhibitor candidates, Dnmt3a-C DNA methylation
kinetics were carried out in the presence of 100 μMo f
compound. Rates of DNA methylation were derived by
linear regression of the initial phase of the reaction pro-
gress curves. The reaction rates were compared with
control reactions carried out after addition of a corre-
sponding volume of DMSO to ensure identical reaction
conditions, because DMSO had been shown before to
i n f l u e n c et h ea c t i v i t yo fD n m t 3 a[ 4 1 ] .A ss h o w ni nF i g -
ure 4, four of the compounds had a substantial inhibi-
tory effect for the in vitro Dnmt3a-C activity (N6-N8
and N12). To determine IC50 values, DNA methylation
kinetics were carried out in the presence of variable
concentrations of the inhibitors, initial slopes derived
and the activity profile analysed by fitting of the experi-
mental data to the equation:
A(cI) =A 0 × cI/(IC50 +c I) +B L
with: cI, concentration of the inhibitor; A(cI), activity
in presence of inhibitor at concentration c; A0, activity
in absence of inhibitor; BL, baseline.
A ss h o w ni nF i g u r e5 ,t h eI C 50 values for the com-
pounds N6-N8 and N12 were all in the lower μM range.
Discussion
Lee et al had showed that caffeic acid and chlorogenic
acid inhibit the activity of M.SssI and Dnmt1 and
decrease the methylation level at the RAR beta promoter
gene in the breast cancer cell lines [12]. Furthermore,
they have recently described the inhibition of human
Dnmt1 by tea flavanoids such as EGCG, catechin and
other flavanoids such as quercitin and myristin, obser-
ving KI values in the low micromolar range [11]. While
Dnmt1 is considered a biological target involved in
Figure 1 Purification of Dnmt3a catalytic domain. Fig. 1 Purified
Dnmt3a-C separated on 12% SDS-PAGE gel and stained with
colloidal Coomassie Blue. (M, Size marker for 116, 66.2, 45, 35 and
25 kDa; L, crude lysate; F, Flow through; W1, Wash1; W2, Wash2; E,
Elution). The purified Dnmt3a-C protein runs at an apparent size of
36 kDa (highlighted with an arrow).
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gated in this study, has been linked to both cancer
development and mental performance and health.
Therefore, any inhibitory interaction between any of the
screened dietary polyphenols and Dnmt3a might allow
identification of compounds that have a positive effect
on cancer prevention and improved mental
performance.
Figure 2 Structures of the compounds tested for Dnmt3a-C inhibition.
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EGCG (N1) with a reported IC50 on Dnmt1 of 0.21 μM
and epigallocatechin (N4) showed only weak inhibition
of Dnmt3a. A slightly increased activity was observed
for theaflavin, theaflavin-3-gallate (N3) and theaflavin 3’-
gallate (N5) with the gallated derivatives showing a lar-
ger inhibitory effect. Theaflavin 3, 3’-digallate (N6) per-
formed best in this series with a measured IC50 value of
44 μM. Similarly, the thearubigin fractions performed
well in this test with IC50 values of 40 μMa n d2 8μM,
respectively (molarity calculated by assuming an average
molecular weight of 800 g/mol). It has to be noted that
according to our knowledge this is the first time that a
thearubigin fraction (consumed at a level of 1 Mt per
annum) has been investigated in an enzyme assay and
found to exhibit inhibitory activity. Previous work on
thearubigins biological activity had focused on interfer-
ence with signalling cascades in the anti-inflammatory
response [42-45]. Due to the structural similarity of
theaflavins and thearubigins (poly-hydroxy theaflavins),
the inhibition of Dnmt3a does not come as a complete
surprise.
To evaluate any possible biological significance of the
IC50 values of Dnmt3a inhibition observed here, human
pharmacokinetic data need to be consulted. Two pub-
lished reports address the pharmacokinetic behaviours
of theaflavins. Mulder and co-workers report theaflavin
concentrations of 4.2 μgl
-1 in urine 2h after consump-
tion of 1 cup of black tea containing 8.8 mg total thea-
flavins [46]. Henning reported a concentration of 2
nmol g
-1 tissue (if converted around 2 μM) of theaflavin
in colon, small intestine, prostate and liver target tissue,
with all further three theaflavins N3, N5 and N6 investi-
gated here showing roughly 1 μM, half this value after
consumption of one cup of black tea [47]. Although no
plasma concentration values are available for theaflavin
derivatives, it can be assumed that the plasma concen-
tration is the same order of magnitude if not even
higher when compared with concentrations in target tis-
sues. As the average per capita consumption of black
tea is around 550 ml or three cups per day, again a
higher physiological concentration must be assumed.
From these data it becomes obvious that out of the com-
pounds investigated theaflavin 3, 3’-digallate N6 is a com-
pound showing reasonable bioavailability. These
concentration estimate of 2 μM is only roughly by one
order of magnitude smaller than the measured IC50 values.
Assuming consumption of a black tea beverage rich in
theaflavins (a maximum of 50 mg l
-1 has been determined)
or repeated consumption of larger quantities of black tea
the measured IC50 values for Dnmt3a inhibition, therefore,
may have biological significance and inhibition of this
enzyme can be expected under physiological conditions
after black tea consumption. No data are available on
thearubigin pharmacokinetics but since a typical cup of
tea contains 60-70% of its dry mass of this mixture of
compounds biological significance can as well be assumed.
Figure 3 Methyltransferase activity of the purified Dnmt3a-C.
Example of the methylation kinetics carried out with purified
Dnmt3a-C. Initial slopes were determined by linear regression
analysis of the initial linear parts of the reaction progress curves.
Figure 4 Initial screening of the 24 compounds for inhibition of Dnmt3a-C. Dnmt3a-C activity was determined in the presence of 100 μM
compound. The control reaction was performed after adding a corresponding volume of DMSO.
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on the problem discussed here and are worth highlight-
ing. Firstly, work by Vauzour et al. showed that dietary
polyphenols from berries of similar polarity and struc-
ture compared to the polyphenols studied here, are able
to cross the blood brain barrier [48], therefore suggest-
ing that brain target tissue could be reached by the
compounds under investigation. Secondly, recent work
by Müller-Harvey et al. reports an accumulation of tea
polyphenols in cell nuclei [49], suggesting that not only
target tissue but target cell organelles, in which Dnmt3a
methylates DNA can indeed be reached by the com-
pounds under investigation.
Coffee polyphenols
Out of the twelve chlorogenic acid derivatives screened,
seven showed a minor inhibitory effect on Dnmt3a with
one compound 1,3-dicaffeoyl-muco-quinic acid diacetal
(N12) showing a good IC50 value of 35 μM. Since com-
pound N12 is a synthetic derivative, not present in the
human diet, this finding has no direct dietary signifi-
cance. However, the activity of compound N12 clearly
indicates that chlorogenic acid derivatives have the
potential to inhibit Dnmt3a and this derivative might
serve as a lead compound to screen and identify further
dietary compound possessing this interesting biological
activity.
Interestingly, all compounds showing inhibitory effects
are diacyl quinic acids, whereas monoacyl quinic acids
showed no effect at all. As a general trend caffeoyl deri-
vatives seem to be more active if compared to feruloyl
derivatives and a 1,3-diacyl regiochemistry appears to be
favourable. Similarly gallic acid and caffeic acid had no
inhibitory effect at all in contrast to the values reported
by Lee & Zhu for Dnmt1 inhibition [12]. Despite the
structural similarity of these two enzymes a predictive
design of inhibitors targeting both classes of enzymes
does not seem possible, which can be turned into an
advantage considering that the compounds investigated
by us and by Lee show remarkable selectivity for either
Dnmt1 or Dnmt3a.
Conclusions
We have shown that the black tea polyphenols, in parti-
cular theaflavin 3, 3’-digallate N6 and thearubigin frac-
tion inhibit Dnmt3a with a physiologically and
Figure 5 Measurement of IC50 values for compounds N6, N7, N8 and N12. For compounds N6, N7, N8 and N11 DNA methylation kinetics
were carried out at different concentration of the compounds to determine the IC50 value. The error bars show the maximal deviations in
repeated experiments. IC50 values are valid by ±30%.
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a novel biological target that is able to rationalize both
anti-carcinogenic activity and mental health and perfor-
mance related activity of black tea.
Methods
Expression and purification of Dnmt3a-C
The mouse Dnmt3a C-terminal domain was expressed
and purified as described [29,30]. The purity of protein
was determined on 12% SDS-PAGE gel stained with col-
loidal Coomassie Blue (Figure 1). Protein concentration
was determined from the absorbance at 280 nm using
an extinction coefficient of 39290 M
-1 cm
-1.
DNA methyltransferase activity assay
Kinetics of Dnmt3a-C was analyzed by using a Biotin-
Avidin methylation kinetics assay basically as described




GAGGAGAGTGCAA-3’; The oligonucleotides were
annealed by heating to 86°C for some minutes and slowly
cooling down to ambient temperature. The methylation
reactions were carried out in methylation buffer [20 mM
HEPES pH 7.2, 1 mM EDTA, 50 mM KCl, 25 mg/ml
bovine serum albumin (BSA)] at 37°C, using 1 μMs u b -
strate DNA, 0.76 μMA d o M e ta n d2 . 5μMD n m t 3 a - C .
After the methylation reaction, the oligonucleotides were
immobilized at various time points on an avidin-coated
microplate. The incorporation of [3H] into the DNA was
quenched by addition of an excess of unlabeled AdoMet
to the binding buffer. Subsequently, unreacted AdoMet
was removed by washing five times with PBST containing
0.5 M NaCl. The immobilized DNA was digested with a
non-specific endonuclease to release the radioactivity from
the microplate. After digestion, 120 μl of the reaction mix-
ture were transferred to a fresh microplate and 160 μlo f
Microscint-PS scintillation fluid (Perkin Elmer) was added
to each well. Finally, the amount of methyl groups trans-
ferred to the DNA and the solution obtained after nucleo-
lytic digestion was quantified by using the TopCount NXT
liquid scintillation counter. To determine the initial slope,
the data were fitted by linear regression of the initial part
of the reaction progress curves.
All the inhibitors were prepared in the DMSO at 5
mM stock. For the screening purpose 100 μM concen-
trations of the inhibitors were used in the reaction mix-
ture. To detemine the apparent IC50 value for the
potential inhibitors, different concentration of the inhi-
bitors were used in the reaction mixture (10 μM, 25
μM, 50 μM, 100 μM, 250 μM, 500 μM). The different
concentrations of the inhibitors were incubated with
Dnmt3a protein for 10 min at room temp. The reaction
was started by adding substrate and cofactor and further
incubated at 37°C for another 10 min then the reaction
was stopped by adding excess unlabelled AdoMet. The
D M S Ow a su s e da sc o n t r o li neach experimental setup
to exclude the possible inhibition effect from the DMSO
itself. All the inhibitor kinetics was done at duplicate
a n ds t a n d a r de r r o rw a sc a l c u l a t e df o rt h et w oe x p e r i -
mental values.
Isolation and synthesis of inhibitors
EGCG N1 and (-)-epigallocatechin (N4), theaflavin (N2),
theaflavin-3-gallate (N3), theaflavin 3’-gallate (N5) and
theaflavin 3, 3’-digallate (N6) were from black tea
obtained using published procedures (Figure 2) [33,51].
Thearubigin fractions (N7 and N8) were obtained from
black tea and characterised using published procedures
[33,51]. All chlorogenic acid derivatives were obtained
by synthesis using published procedures (Figure 2) [52].
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